Vinpocetine
A semi-synthetic periwinkle alkaloid that is a prescription drug in much of the world and should not be treated as a food ingredient. The evidence for cognitive benefit has been inconclusive for over twenty years, and it carries a documented developmental toxicity risk in pregnancy.
What the science says
- Cognitive impairment and dementia Limited evidence
The Cochrane review of vinpocetine for cognitive impairment and dementia pooled three trials at 30-60 mg/day and concluded the evidence was inconclusive, with no reliable demonstration of clinical benefit. No adequately powered trial has been published since to change that conclusion.
- Post-stroke cognitive function and cerebral blood flow Limited evidence
Vinpocetine measurably increases cerebral blood flow and glucose uptake in imaging studies, which is the mechanistic basis for its use after stroke. Clinical trials in post-stroke cognitive dysfunction are small, mostly open-label and largely from single regions, and umbrella reviews of post-stroke therapies rate the supporting evidence as low certainty.
- Product quality and dose accuracy Moderate evidence
An analysis of US dietary supplements labelled as containing vinpocetine found the measured amount varied widely from the declared dose, with some products containing none at all and others delivering pharmaceutical-range quantities. Consumers cannot reliably know what dose they are taking.
Dosage & safety
Scientific references
Where to buy
Life Extension, Vinpocetine, 100 Vegetarian Tablets
View on iHerbReferral link — this site may earn a commission on purchases.
Related in Brain & cognition
- Vitamin B2 (Riboflavin) Moderate evidence
- Choline Moderate evidence
- Magnesium L-Threonate Limited evidence
- Phosphatidylserine Limited evidence
- Lecithin (Phosphatidylcholine) Limited evidence
- Agmatine Sulfate Limited evidence